CLOSING: ASTRAZENECA
Just reading the blog on WSJ and talking to our spec sits desk and it looks like the bump is not possible now. Its a bit too messy and although they technically have till Monday it seems unless the AZN board accepts the £55 a share offer(which they have already rejected) there is no more…